Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Reexamination Certificate
2007-10-31
2010-02-02
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
C546S014000
Reexamination Certificate
active
07655640
ABSTRACT:
A method of inhibiting topoisomerase I mediated DNA cleavage including administering a pharmaceutically effective amount of a compound having the following formula or a pharmaceutically acceptable salt thereof:wherein R1and R2are independently the same or different and are hydrogen, an alkyl group, an aminoalkyl group, an alkylaminoalkyl group, a haloalkyl group, a hydroxyalkyl group, an alkenyl group, an alkynyl group, an alkoxyl group, an aryloxy group, a carbamoyloxy group, a halogen, a hydroxyl group, a nitro group, a cyano group, an azido group, a formyl group, a hydrazino group, —C(O)Rf, an amino group, an alkylamino group, a dialkylamino group, —SRc, or R1and R2together form a group of the formula —O(CH2)nO— wherein n represents the integer 1 or 2; R3is H, F, a halogen atom, a nitro group, an amino group, a hydroxyl group, or a cyano group; or R2and R3 together form —O(CH2)nO— (n=1 or 2); R4is H, F, a C1-3alkyl group, a C2-3alkenyl group, a C2-3alkynyl group, or a C1-3alkoxyl group; R5is a C1-10alkyl group, or a propargyl group.
REFERENCES:
patent: 5468859 (1995-11-01), Fortunak
patent: 5700939 (1997-12-01), Fortunak
patent: 5744605 (1998-04-01), Curran
patent: 5910491 (1999-06-01), Hausheer
patent: 6057303 (2000-05-01), Haridas
patent: 6136978 (2000-10-01), Curran et al.
patent: 6150343 (2000-11-01), Curran
patent: 6169080 (2001-01-01), Hausheer et al.
patent: 6211371 (2001-04-01), Curran
patent: 6252079 (2001-06-01), Curran
patent: 6403604 (2002-06-01), Yang et al.
patent: 6455699 (2002-09-01), Curran et al.
patent: 6743917 (2004-06-01), Curran et al.
patent: 7271159 (2007-09-01), Curran et al.
patent: 2009/0099166 (2009-04-01), Narkunan et al.
patent: 40204/97 (1998-03-01), None
patent: WO 98/07727 (1998-02-01), None
patent: WO 98/35940 (1998-08-01), None
patent: WO 98/35940 (1998-08-01), None
patent: WO 99/01456 (1999-01-01), None
patent: WO 99/09996 (1999-03-01), None
Fassberg, J. et al.; A Kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some Analogues; Journal of Pharmaceutical Sciences; 1992; vol. 81; No. 7; 676-684.
Curran, D.P. and Liu, H., “New 4+1 Radical Annulations—A Formal Total Synthesis of (+/−) -Camptothecin,” J. Am. Chem Soc., 114, 5863-5864 (1992). Published Jul. 1, 1992.
Curran, D.P., “The Camptothecins—A reborn Family of Antitumor Agents”, J. Chin. Chem. Soc., 40, 1-6 (1993). Published Feb. 1993.
Curran, D.P. et al., “Recent Applications of Radical Reactions in Natural Product Synthesis,” Pure Appl. Chem., 65, 1153-1159 (1993). Published Jun. 1993.
Curran, D.P. et al., “Cascade Radical Reactions of Isonitriles: A Second-Generation Synthesis of (20S)-Camptothecin, Topotecan, Irinotecan, and GI-147211C,” Angew. Chem. Int. Ed, 34, 2683-2684 (1995). Published Jan. 5, 1996.
Curran, D.P., Liu, H.; Josien, H; Ko, S.B., “Tandem Radical Reactions of Isonitriles with 2-pyrdonyl and other aryl radicals: Scope and Limitations, and a First Generation Sunthesis of (+/−)-Camptothecin,” Tetrahedron, 52, 11385-11404 (1996). Published Aug. 1996.
Josien, H. and Curran, D.P., “Synthesis of (S)-mappicine and Mappicine Ketone Via Radical Cascade Reaction of Isonitirles,” Tetrahedron, 53, 8881-8886 (1997). Published Jun. 30, 1997.
Liu, H. et al., “Selective N-Functionalization of 6-Substituted-2-Pyridones,” Tetrahedron Letters, 36:49, 8917-8920 (1995).
Josien H. et; al. “7-Silylcamptothecins (Silatecans): A New Family of Camptothecin Antitumor Agents”, Bioorganic & medical Chemistry Letters, Oxford, GB, vol. 7, No. 24, Dec. 16, 1997, pp. 3189-3194.
Wall M.E. et. al. “camptothecin and Taxol: From Discovery to Clinic”, Journal of Ethnopharmacology, vol. 51, 1996, pp. 239-254.
Goldwasser F. et. al. “potentiation of Cisplatin Cytotoxicity by 9-Aminocamtothecin”, Clinical Cancer Research, vol. 2, Apr. 1996, pp. 687-693.
Curran Dennis P.
David Bom
Josien Hubert
Bartony & Associates LLC
Berch Mark L
University of Pittsburgh - of The Commonwealth System of Higher
LandOfFree
Camptothecin analogs and methods of preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Camptothecin analogs and methods of preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Camptothecin analogs and methods of preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4182086